StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) stock

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.44−0.07 (-4.95%)

Close on Nov 16, 2026Market cap $6.45MP/E –Yield –

Earnings

Enveric Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 26, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
$0.57
-$10.81 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Enveric Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 26, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026after the close––$0.57Release
Q2 FY2026ended Jun 30, 2026Aug 14, 2026during market hours––$0.76Release
Q1 FY2026ended Mar 31, 2026May 15, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Mar 27, 2026during market hours––-$6.12Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025during market hours––-$10.81Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open––-$0.97Release
Q1 FY2025ended Mar 31, 2025May 14, 2025during market hours––$1.22Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025before the open––-$4.83Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024during market hours––-$0.24Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024during market hours––$0.23Release
Q1 FY2024ended Mar 31, 2024May 15, 2024after the close––$0.61Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Enveric Biosciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Enveric Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Enveric Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. News
  6. News
  7. News
  8. Results
  9. Update
  10. Results
  11. News
  12. Update
  13. Update
  14. Results
  15. Results

See a number that looks wrong?